Picture of Wakamoto Pharmaceutical logo

4512 — Wakamoto Pharmaceutical News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareAdventurousMicro CapNeutral

Table: Wakamoto Pharm - 6-MTH parent results

Nov 1 (Reuters)- 
             Wakamoto Pharmaceutical Co Ltd 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended        Year to  
                Sep 30, 2018        Sep 30, 2017      Mar 31, 2019  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales             5.23                5.42              11.10     
                 (-3.6 pct)          (-1.2 pct)        (+1.8 pct)   
  Operating      loss 44 mln        loss 105 mln      loss 510 mln  
  Recurring      loss 29 mln        loss 108 mln      loss 510 mln  
  Net            loss 31 mln         loss 84 mln      loss 380 mln  
  EPS           loss 0.91 yen       loss 2.43 yen    loss 10.95 yen 
  Ann Div                             3.00 yen                      
  -Q2 div            NIL                 NIL                        
  -Q4 div                             3.00 yen                      
  
  NOTE - Wakamoto Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4512.T

Recent news on Wakamoto Pharmaceutical

See all news